Barclays’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $0 | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $47K | Sell |
|
|||||
|
2023
Q4 | $69K | Buy |
|
|||||
|
2023
Q3 | $25K | Sell |
|
|||||
|
2023
Q2 | $56K | Sell |
|
|||||
|
2023
Q1 | $1.16M | Buy |
|
|||||
|
2022
Q4 | $942K | Sell |
|
|||||
|
2022
Q3 | $1.31M | Buy |
|
|||||
|
2022
Q2 | $168K | Sell |
|
|||||
|
2022
Q1 | $688K | Sell |
|
|||||
|
2021
Q4 | $3.67M | Sell |
|
|||||
|
2021
Q3 | $5.43M | Sell |
|
|||||
|
2021
Q2 | $4.79M | Buy |
|
|||||
|
2021
Q1 | $2.61M | Buy |
|
|||||
|
2020
Q4 | $1.36M | Sell |
|
|||||
|
2020
Q3 | $1.03M | Sell |
|
|||||
|
2020
Q2 | $1.55M | Buy |
|
|||||
|
2020
Q1 | $683K | Buy |
|
|||||
|
2019
Q4 | $1.08M | Buy |
|
|||||
|
2019
Q3 | $526K | Sell |
|
|||||
|
2019
Q2 | $1.74M | Buy |
|
|||||
|
2019
Q1 | $567K | Sell |
|
|||||
|
2018
Q4 | $1.44M | Buy |
|
|||||
|
2018
Q3 | $674K | Buy |
|
|||||
|
2018
Q2 | $110K | Sell |
|
|||||
|
2018
Q1 | $335K | Sell |
|
|||||
|
2017
Q4 | $158K | Sell |
|
|||||
|
2017
Q3 | $264K | Sell |
|
|||||
|
2017
Q2 | $235K | Buy |
|
|||||
|
2017
Q1 | $189K | Buy |
|
|||||
|
2016
Q4 | $121K | Buy |
|
|||||
|
2016
Q3 | $8K | Sell |
|
|||||
|
2016
Q2 | $108K | Buy |
|
|||||
|
2016
Q1 | $4K | Sell |
|
|||||
|
2015
Q4 | $18K | Buy |
|
|||||
|
2015
Q3 | $6K | Sell |
|
|||||
|
2015
Q2 | $14K | Buy |
|
|||||
|
2015
Q1 | $8K | Sell |
|
|||||
|
2014
Q4 | $12K | Buy |
|